Pharmacy and Therapeutics Committee (P&T)


By statute (NRS 422.402-422.405), the State of Nevada requires the DHCFP to establish and maintain a Preferred Drug List (PDL). The Pharmacy and Therapeutics Committee (P&T) was established to identify prescription drugs to be included on the PDL.
The P&T consists of at least 5 but not more than 11 members who are Governor-appointed physicians pharmacists. Meetings are held quarterly. The PDL is not restricted formulary. Drugs not on the PDL are still available to recipients if they meet the Standard Preferred Drug List Exception criteria.

For pharmacists and physicians wishing to serve on the Pharmacy & Therapeutics Committee, please visit the Governor's Boards and Commissions webpage using the link provided on the right. 

Last Edited: 9/14/2017